Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston blog main
clinical trials
drugs
life sciences
national blog main
rna interference
a2a pharmaceuticals
accelerated approval
acute hepatic porphyria
alirocumab
amgen
aminolevulinic acid
artificial intelligence
atea pharmaceuticals
big data
biotech
boston
boston top stories
business
category-/health/health conditions
cloud
coronavirus
covid-19
dev
enterprise
evercore isi
evolocumab
givosiran
health care
heart attack
inclisiran
insilico medicine
joseph swartz
medicines co.
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
What
drug
5
×
new
5
×
pharmaceuticals
5
×
medicine
alnylam
cure
data
far
rna
aa
adamis
administration
advances
allergy
alternative
announced
antiviral
applying
approved
artificial
atea
based
cheaper
cholesterol
clear
cleared
compete
consortium.ai
coronavirus
corporation
cost
criticized
currently
cutting
deal
developme
directly
discovery
diseases
edge
Language
unset
Current search:
pharmaceuticals
×
new
×
drug
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@venturebeat.com
5 years ago
Consortium.AI wants to cure rare diseases using artificial intelligence
@theverge.com
6 years ago
Cheaper alternative to EpiPen allergy shot approved by FDA